Master the CTA lower extremity runoff protocol: bolus-tracking parameters, calcium blooming pitfalls, and PAD detection tips for radiology teams.

CTA Lower Extremity Runoff: 7 Critical Protocol Steps

Introduction: why lower extremity CTA runoff is a high-stakes study

The CTA lower extremity runoff protocol is the single examination that most directly determines whether a patient with suspected peripheral arterial disease proceeds to angioplasty, bypass, or amputation. Unlike a head or chest CTA, this study must track a single contrast bolus over more than a metre of vascular territory — from the infrarenal aorta down to the pedal arch — while that bolus is actively decelerating, diluting, and sometimes failing to reach the periphery at all.

Peripheral arterial disease (PAD) now affects more than 200 million people worldwide, and its prevalence and mortality burden continue to climb even as coronary and cerebrovascular disease rates fall^[1]. For radiology departments, this growing burden translates directly into rising runoff CTA volumes, which makes consistent, protocol-driven execution of this study an increasingly central part of day-to-day departmental workflow rather than a niche or occasional examination. As referral volumes grow, so too does the cumulative impact of any single systematic error in technique or interpretation, which is exactly why the two pitfalls explored in this article deserve sustained departmental attention rather than one-off training.

Radiographers must execute a precisely choreographed bolus-tracking acquisition that adapts to each patient’s cardiac output, while radiologists must distinguish true occlusion from calcium blooming artifact in heavily calcified, diabetic, or dialysis-dependent limbs. Get either piece wrong, and the consequence is not a repeat scan — it is a missed window for limb salvage. This article walks through the complete lower extremity CTA runoff protocol used across the 30-Day CT Protocol Mastery Series, with full attention to the scanning pitfall of outrunning the contrast bolus and the interpretation pitfall of calcium blooming.

The financial and human cost of getting this study wrong is substantial: a missed or mischaracterized occlusion can mean an unnecessary major amputation, while an under-recognized acute embolic event can mean the loss of a salvageable limb within hours, which is why this particular protocol deserves the same level of institutional attention typically reserved for stroke or trauma imaging pathways, even though it rarely carries the same emergency department visibility.

Common clinical indications encountered in practice

• Lifestyle-limiting intermittent claudication that has failed an adequate trial of supervised exercise therapy and guideline-directed medical management, where the referring team is now weighing revascularization.
• Suspected acute limb ischemia, presenting with the classic “six P’s” — pain, pallor, pulselessness, paresthesia, paralysis, and poikilothermia — where rapid localization of the occluding lesion directly shapes the urgency and modality of intervention.
• Pre-operative or pre-endovascular planning for a patient already selected for revascularization, where the surgeon or interventionalist needs a complete inflow-to-outflow roadmap rather than a focused single-segment assessment.
• Surveillance of a prior bypass graft or stent for restenosis or graft failure, particularly in patients with new or recurrent symptoms after an initially successful procedure.
• Non-healing diabetic foot ulceration, where arterial inflow status determines whether wound-care measures alone are realistic or whether revascularization must precede any expectation of healing.
• Suspected vascular trauma following penetrating or blunt lower extremity injury, where rapid identification of an arterial injury can be limb-saving.

This protocol sits in deliberate contrast to the bolus-tracking strategies used in cerebral or coronary CTA, where transit times are short and predictable. In the lower extremity, blood must traverse a long, often diseased arterial tree before contrast opacification peaks in the calf and foot vessels, and that transit time is precisely what fails in the patients who need this scan the most — those with severe, multilevel atherosclerotic disease and a low cardiac output.

CTA has become the dominant first-line advanced imaging modality for lower extremity runoff in most departments, largely because it offers near-isotropic spatial resolution, rapid acquisition, and the ability to characterize the vessel wall itself — not just the lumen — in a single outpatient visit.

Catheter-based digital subtraction angiography (DSA) remains the invasive reference standard against which CTA accuracy is measured, but it carries arterial puncture risk and is now reserved largely for cases proceeding directly to intervention. Magnetic resonance angiography (MRA) avoids ionizing radiation and iodinated contrast entirely, which makes it attractive in patients with severe renal impairment, but it remains more susceptible to motion artifact over a long field of view and is less widely available out of hours.

Duplex ultrasound is an excellent first-line, radiation-free screening tool, but its accuracy falls sharply in heavily calcified, multilevel, or aorto-iliac disease, and it cannot reliably generate the single comprehensive roadmap that a surgeon or interventionalist needs before committing to a revascularization strategy.

Within this competitive landscape, CTA’s central advantage — and its central vulnerability — is the same physical phenomenon: a single intravenous bolus must remain diagnostically opaque across an enormous craniocaudal distance while the scanner physically follows it down the leg. Every other section of this article traces back to that one constraint, whether the topic is bolus-tracking ROI placement, table speed, contrast volume, or the calcium-related interpretive pitfalls that follow from trying to see through a long, often densely calcified tube of contrast-filled blood.

Anatomy and Hounsfield unit values

The lower extremity runoff field of view extends from the infrarenal abdominal aorta through the common and external iliac arteries, common femoral artery, profunda and superficial femoral arteries, the adductor (Hunter’s) canal, popliteal artery, and the three tibial trunks — anterior tibial, posterior tibial, and peroneal (fibular) arteries — terminating at the pedal arch. Each segment has a distinct propensity for disease: the superficial femoral artery at the adductor canal and the proximal popliteal artery are the most common sites of focal atherosclerotic occlusion, while the tibial trunks are disproportionately affected in diabetic and dialysis-dependent patients, who develop a more distal, heavily calcified pattern of disease.

This proximal-to-distal disease gradient has direct interpretive consequences. A non-diabetic patient with isolated claudication frequently demonstrates a single, focal area of severe stenosis or occlusion at the adductor canal, with otherwise preserved inflow and outflow vessels — a pattern well suited to a focal endovascular intervention. A diabetic patient with the same symptom, by contrast, more often demonstrates diffuse, multisegment tibial disease that may not have a single, fixable culprit lesion at all, which is part of why diabetic PAD carries a comparatively higher rate of progression to chronic limb-threatening ischemia and major amputation despite broadly similar overall arterial calcium burden.

Gross anatomy and collateral pathways

A working knowledge of collateral anatomy is essential for interpreting runoff studies, because collaterals are often the only clue that a “complete cutoff” on a single reconstructed plane is in fact a chronic, well-compensated occlusion rather than an acute ischemic event. The geniculate collateral network around the knee, fed by the descending genicular branch of the superficial femoral artery and the genicular branches of the popliteal artery, frequently reconstitutes flow below a popliteal occlusion. Similarly, the profunda femoris artery and its perforating branches provide a robust collateral pathway around superficial femoral artery occlusions, which is why isolated SFA disease is often well tolerated clinically even when the native vessel is completely occluded.

Below the knee, the tibial trunks communicate through small intermuscular collateral vessels that are rarely visible on standard CTA but can be inferred from a gradual, tapering reduction in vessel caliber rather than an abrupt cutoff. Recognizing this gradual-versus-abrupt distinction is one of the most important interpretive skills for runoff studies, since it directly informs whether an occlusion is likely to be acute (abrupt, meniscus-shaped contrast column, minimal collateralization) or chronic (smooth taper, rich collateral network, often calcified vessel walls).

A systematic vessel-by-vessel review checklist

Because lower extremity runoff studies contain so many named vessels across both limbs, an unstructured “scroll and look” approach to interpretation invites missed segments, particularly in the tibial trunks where three parallel vessels must each be traced individually. A reproducible, segment-by-segment review pattern reduces this risk substantially. Most experienced readers work proximal to distal, on each limb in turn, rather than alternating between limbs at every level, since this minimizes the cognitive load of holding multiple vessel courses in mind simultaneously.

• Infrarenal aorta and iliac arteries. Assess for aneurysmal dilation, mural thrombus, and any iliac stenosis that would compromise inflow to an otherwise normal femoropopliteal segment.
• Common femoral artery and femoral bifurcation. A common site for calcified plaque and a critical landmark for surgical or endovascular access planning.
• Profunda femoris artery. Frequently the dominant collateral pathway when the superficial femoral artery is occluded; its patency can determine whether a patient remains asymptomatic despite SFA disease.
• Superficial femoral artery, particularly at the adductor canal. The single most common site of focal atherosclerotic occlusion in the lower extremity.
• Popliteal artery, above and below the knee joint line. Assess specifically for aneurysmal dilation and for the anatomic relationship between the artery and the medial head of gastrocnemius, which is abnormal in popliteal entrapment syndrome.
• Tibioperoneal trunk and its trifurcation. A frequent watershed point where proximal disease can abruptly transition to a three-vessel runoff assessment.
• Anterior tibial, posterior tibial, and peroneal arteries individually. Each vessel must be traced in continuity to its terminal branches; it is not sufficient to confirm that “a” tibial vessel remains patent if the clinical question concerns a specific angiosome.
• Pedal arch and forefoot vessels. Often the most technically challenging segment to opacify adequately, and the segment most directly affected by the outrunning-the-bolus pitfall described later in this article.

Angiosomes and wound-directed revascularization

For patients referred specifically for non-healing diabetic foot ulceration, the runoff report carries an additional layer of clinical relevance beyond simple patency assessment: the concept of the angiosome, a three-dimensional block of skin and soft tissue supplied by a specific named source artery. The foot is conventionally divided into angiosomes supplied respectively by branches of the anterior tibial, posterior tibial, and peroneal arteries, and successful wound healing after revascularization is more reliable when flow is restored specifically to the artery supplying the angiosome containing the wound, rather than to any patent vessel in the leg.

A radiologist who identifies that the posterior tibial artery is occluded while the anterior tibial artery remains patent, for example, should consider explicitly noting which forefoot regions each vessel is likely to supply, since this detail can materially change the interventionalist’s target vessel selection.

Scanning technique: 7 critical steps

Lower extremity CTA runoff is unforgiving of timing errors because, unlike a chest or brain CTA, the table must travel the full length of both legs while contrast is actively transiting and diluting. The following seven steps reflect current evidence-based practice for this protocol.

1. Patient positioning and preparation. Position the patient supine, feet together and internally rotated 10–15° to separate the tibia and fibula and reduce overlap of the anterior and posterior tibial arteries. Secure the feet with tape or a foam wedge to prevent motion during the multi-minute acquisition, and confirm that both legs are fully within the scan field — missing the distal foot vessels is a common and entirely avoidable error in tall patients. Remove any metal jewellery or clothing fasteners from the lower limbs, and document any retained orthopaedic hardware or vascular stents before the radiologist reviews the study, since these can otherwise be mistaken for unexpected findings during reporting.
2. IV access and injector setup. Establish an 18–20 gauge antecubital IV, since the long acquisition and saline chaser require a robust, pressure-rated line. Programme the dual-head injector for 100 mL of contrast media at 4.0 mL/s followed immediately by a 100 mL saline chaser at the same rate, which both clears the injection-side veins and pushes the trailing edge of the contrast column further down the leg. Confirm injector pressure limits are appropriate for the gauge of cannula in use, and visually inspect the IV site for early signs of extravasation in the first few seconds of injection, since this protocol’s long acquisition window leaves little room to recover from a failed bolus.
3. Scanogram and planning. Acquire a full anteroposterior scanogram from the renal arteries to below the feet to confirm coverage, plan the bolus-tracking region of interest, and identify any retained metal (prior stents, orthopaedic hardware) that may require adjusted reconstruction kernels. Use this planning step to also confirm symmetric leg positioning, since an asymmetrically rotated limb can introduce confusing overlap artifact on the subsequent maximum intensity projection reconstructions.
4. Bolus-tracking trigger placement. Place the region of interest in the distal abdominal aorta, just above the aortic bifurcation, with a trigger threshold of 120 HU. This location is chosen specifically because it sits proximal to the diseased segments most likely to slow contrast transit, giving the scanner the earliest reliable signal of bolus arrival before the contrast must traverse potentially stenotic iliofemoral disease. Avoid placing the ROI directly over a calcified plaque or vessel wall, since this can produce spurious density readings that either trigger the acquisition prematurely or fail to trigger it at all.
5. Acquisition parameters. Scan at 100 kVp, 250–400 mA (modulated to patient habitus), pitch 0.8, and 0.5 s rotation time, using the fastest available table speed consistent with image quality. The relatively low kVp improves iodine contrast-to-noise ratio and supports dose reduction, but must be balanced against beam-hardening artifact in heavily calcified vessels. In larger patients, an increase to 120 kVp may be justified to maintain adequate penetration through thigh soft tissue, with a corresponding adjustment to automatic exposure control settings.
6. Table speed matched to predicted bolus transit. This is the step most directly tied to the central scanning pitfall of this protocol. In patients with severe PAD or reduced cardiac output, contrast travels down the leg more slowly than the scanner’s default caudocranial-to-caudal table speed assumes, and an unmodified fast acquisition can reach the ankle and foot before contrast has arrived there — producing a falsely “occluded-appearing” distal vasculature that is in fact simply unopacified. Radiographers should be prepared to manually extend the post-trigger delay or reduce table speed in patients with known severe multilevel disease, low ejection fraction, or extensive prior bypass surgery. Some departments use a fixed empirical delay (commonly an additional 5–10 seconds beyond the standard calculation) for patients flagged as high risk for delayed transit, while others rely on real-time visual monitoring of contrast arrival on a secondary tracking image.
7. Reconstruction and multiplanar review. Reconstruct thin-section (0.625–1.0 mm) axial images plus curved planar reformats following the course of each named vessel, in addition to coronal and sagittal maximum intensity projection (MIP) and volume-rendered 3-D images. Axial source images remain the primary diagnostic dataset for stenosis grading; MIP and 3-D renderings are adjuncts for surgical planning and patient communication, not substitutes for source-image review. Bone-removal post-processing algorithms can further declutter the 3-D rendering for surgical discussion, but the underlying axial dataset should always be retained and reviewed in parallel.

Scanner comparison: 16-slice to 320-slice systems

A recurring theme across this comparison is that faster scanner hardware does not, by itself, solve the bolus-timing challenge central to this protocol — and in some respects makes it more acute. A 16-slice system’s slower table speed inadvertently provided a built-in margin of safety against outrunning a slow bolus, simply because the acquisition itself took longer. As departments upgrade to wide-detector and dual-source platforms capable of covering the same anatomic range in a third of the time, protocol delay settings and table speed limits must be deliberately reviewed and, where necessary, throttled back for high-risk patients rather than left at a manufacturer default tuned for an average, non-diseased vascular bed.

Dual-energy and photon-counting protocols

It is worth emphasizing that none of these advanced acquisition modes are mandatory for producing a diagnostic lower extremity runoff study — the vast majority of departments worldwide continue to perform this protocol successfully on conventional single-energy CT, and the seven-step technique described above applies regardless of whether dual-energy or photon-counting hardware is available. Where these technologies are available, however, they offer a direct, hardware-level mitigation against the calcium blooming pitfall discussed later in this article, and departments with a high proportion of diabetic or dialysis-dependent referrals may find the additional acquisition and reconstruction time well justified by the corresponding gain in diagnostic confidence.

Deep learning reconstruction (DLR)

Deep learning reconstruction algorithms, now available across most major vendor platforms, are increasingly used in lower extremity CTA to suppress image noise at lower radiation dose and lower tube current settings than traditional iterative reconstruction allows. For runoff studies specifically, DLR is particularly valuable in the distal calf and foot, where vessel caliber is small and the contrast-to-noise ratio is already at its lowest point of the entire acquisition. Departments adopting DLR for this protocol typically report the ability to reduce mA settings at the lower legs without a corresponding loss of diagnostic confidence in tibial vessel patency assessment.

Adaptive and real-time bolus monitoring

Several scanner platforms now support an extended bolus-tracking workflow in which the operator can visually confirm contrast arrival at a second, more distal monitoring location — such as the popliteal artery — before the diagnostic acquisition proceeds, rather than relying solely on a single proximal aortic trigger and a fixed calculated delay. Comparative work evaluating popliteal artery monitoring alongside dual-energy acquisition in a dual-low-dose protocol (reduced radiation and reduced contrast volume) found that this approach maintained signal-to-noise and contrast-to-noise performance across the seven major arterial segments assessed, while supporting meaningful contrast and dose reduction relative to a conventional abdominal-aorta-monitored protocol^[9].

For departments managing a high proportion of severe, multilevel PAD referrals, building this kind of distal confirmation step into the standard workflow can directly reduce the incidence of the outrunning-the-bolus pitfall, since the technologist receives direct visual evidence of contrast arrival in the leg itself rather than inferring it purely from a calculated delay anchored to the aorta.

Contrast media protocol

The contrast strategy for lower extremity CTA runoff must solve a fundamentally different problem than most CTA protocols: it must keep a single bolus diagnostically opacified across a vascular bed that may be over a metre long and partially obstructed by the very disease being investigated. The standard protocol calls for 100 mL of iodinated contrast media at a concentration of 350–400 mgI/mL, injected at 4.0 mL/s, followed by a 100 mL saline chaser at the same rate.

Why bolus tracking at the distal aorta — not the popliteal artery

Although some institutions monitor the popliteal artery directly to reduce both contrast and radiation dose^[9], the more conservative and widely used approach triggers at the distal abdominal aorta at 120 HU. This proximal trigger point gives the technologist a margin of safety: because the aorta opacifies well before disease in the iliofemoral or femoropopliteal segments can slow the bolus, the scanner detects bolus arrival reliably even in patients whose distal transit time will later prove markedly delayed. The trade-off is that the post-trigger delay must then be calculated — or, in adaptive systems, monitored — to account for the additional transit time to the feet, which is precisely where the outrunning-the-bolus pitfall originates.

Test bolus versus automatic triggering

A small minority of departments still use a formal test bolus — a 15–20 mL test injection with serial low-dose monitoring images — to empirically measure aorto-pedal transit time in patients with known severe disease before committing to the full diagnostic bolus. This approach adds time and a small additional contrast and radiation burden, but it converts an estimate into a measurement, which can be valuable in patients with unusually unpredictable hemodynamics, such as those with a mechanical circulatory support device, severe aortic regurgitation, or an extensively reconstructed arterial tree from prior bypass surgery.

For the majority of patients, however, an automatic triggering approach with a sensibly extended delay for high-risk individuals remains the practical standard, since it avoids the additional contrast load of a separate test injection.

Ultra-low and reduced-volume contrast strategies

Feasibility studies of ultra-low-volume contrast protocols for PAD CTA — using as little as 30 mL of contrast with a 40 mL saline chaser on dual-source systems at reduced tube voltage — have demonstrated diagnostically adequate image quality while substantially reducing both iodine load and radiation dose^[3]. Similarly, low-iodine virtual monoenergetic protocols combining a reduced contrast bolus with low-keV reconstructions have achieved diagnostic-quality opacification across the major tibial segments^[5]. These reduced-volume approaches are particularly relevant for patients with borderline renal function, though most general radiology departments continue to use a standard 90–120 mL bolus as the default for predictable, reproducible opacification across all body habitus types.

Tailoring the bolus to the individual patient

No single fixed contrast protocol performs equally well across every patient referred for runoff CTA, and a degree of individualization is appropriate. Larger patients generally benefit from a higher iodine concentration (370–400 mgI/mL) to maintain adequate vascular attenuation across a thicker soft-tissue envelope. Patients with a known low cardiac output, severe heart failure, or extensive multilevel disease are reasonable candidates for an extended post-trigger delay, a slower table speed, or — where available — adaptive distal bolus monitoring, since their physiology is precisely the scenario in which the standard timing assumptions break down.

Conversely, younger patients with isolated, non-calcified disease such as suspected popliteal entrapment generally tolerate the standard protocol without modification, since their overall cardiovascular transit time is unlikely to be significantly delayed.

Saline chaser rationale

The 100 mL saline chaser performs two functions in this protocol. First, it clears residual contrast from the antecubital vein and proximal central veins, reducing streak artifact at the injection site and limiting venous contamination that could otherwise obscure adjacent arterial structures in the pelvis. Second, and more importantly for this particular study, it acts as a “pusher” that extends the effective length and duration of the contrast bolus as it travels distally, helping sustain diagnostic opacification in the tibial and pedal vessels for longer than the contrast volume alone would achieve.

Patient communication before the scan

Because this protocol involves a longer table journey, a larger contrast volume, and a longer breath-hold-free but motion-sensitive acquisition than most CT examinations, brief but specific pre-scan communication improves both patient cooperation and image quality. Patients should be told to expect a warm sensation as the contrast is injected, that the table will move continuously rather than in discrete steps, and that they must keep both legs still — including the toes — for the full duration of the acquisition.

Patients with known severe claudication should be offered the opportunity to reposition or rest briefly before the scan begins, since pain-related involuntary movement during acquisition is a preventable source of motion artifact in exactly the population most likely to need a diagnostically reliable result.

Radiation dose and diagnostic reference levels

Lower extremity CTA runoff covers a longer scan range than almost any other routine CT examination, which makes cumulative dose management — rather than per-slice dose alone — the central radiation-protection challenge of this protocol. Because the legs contain comparatively little radiosensitive organ tissue relative to the trunk, however, the per-centimetre effective dose contribution of the leg portion of the scan is low; most of the effective dose burden comes from the abdominal and pelvic portion of the acquisition.

This uneven distribution of dose across the scan range has a direct practical implication for protocol design: tube current modulation should be programmed to taper meaningfully once the acquisition passes the pelvis, and departments that apply a single fixed mA value across the entire abdomen-to-foot range are very likely over-radiating the thigh and leg segments without any corresponding gain in diagnostic image quality. Size-specific dose estimates (SSDE) are particularly useful for this protocol precisely because they correct for the substantial difference in patient cross-sectional area between the abdomen and the calf, which CTDIvol alone — calculated against a fixed reference phantom — does not capture.

Internationally harmonized diagnostic reference levels (DRLs) specific to lower extremity CTA runoff remain less standardized than for brain, chest, or abdominal CT, reflecting the relative infrequency of this study compared with higher-volume protocols. Departments are encouraged to benchmark locally collected dose data against national audits and the European Commission’s diagnostic reference level framework^[19], in addition to International Commission on Radiological Protection guidance on establishing and applying DRLs^[17][18].

Beyond DRL benchmarking, the broader principle of justification — confirming that the expected clinical benefit of the study outweighs the radiation risk for this specific patient before it is performed — deserves explicit attention for runoff CTA specifically, because the patient population skews older and frequently has prior or anticipated future vascular imaging needs. A patient undergoing surveillance after bypass surgery, for example, may accumulate several CTA runoff studies over a multi-year follow-up period, which makes cumulative dose tracking across repeated studies a meaningful institutional responsibility rather than a single-study consideration alone.

Radiology departments that maintain a longitudinal dose record accessible at the point of ordering are better positioned to flag patients approaching a cumulative threshold that might prompt a conversation about substituting a lower-dose alternative such as duplex ultrasound or MRA for a planned surveillance study.

Five dose reduction strategies

1. Reduce tube voltage to 100 kVp (or 80 kVp in lighter patients). Lower kVp improves iodine attenuation and contrast-to-noise ratio while reducing dose, provided automatic exposure control compensates appropriately for increased noise. This is especially effective in runoff studies because the diagnostic target — iodinated blood in a vessel lumen — benefits disproportionately from lower-energy photon attenuation relative to surrounding soft tissue.
2. Apply automatic tube current modulation along the full scan length. The leg segments require substantially less mA than the abdomen and pelvis; modulation prevents over-radiating low-attenuation tissue. Confirm that modulation settings are configured for the full anatomic range of this protocol specifically, rather than inherited unmodified from an abdominal or chest protocol template.
3. Use iterative or deep learning reconstruction. Both techniques permit further mA reduction without a proportional increase in diagnostic noise, particularly valuable in the lower-contrast distal calf vessels, where even modest noise reduction can meaningfully improve confidence in tibial vessel patency assessment.
4. Adopt reduced-volume, lower-iodine contrast protocols where clinically appropriate. Lower iodine load combined with virtual monoenergetic reconstruction can maintain vascular contrast-to-noise ratio while supporting lower-dose acquisition parameters^[5]. This strategy carries the added benefit of reducing iodine burden in a patient population with a disproportionately high prevalence of chronic kidney disease.
5. Limit the craniocaudal scan range to the clinically indicated territory. Confirm on the scanogram that the field of view begins no higher than the renal arteries and ends just below the pedal arch, avoiding unnecessary dose to tissue outside the diagnostic question. A scan range extended unnecessarily into the chest or well below the feet adds dose without adding diagnostic value, and is one of the simplest and most easily corrected sources of avoidable exposure in this protocol.

These strategies are intended to align departmental practice with the spirit of the ALARA (as low as reasonably achievable) principle as articulated in International Commission on Radiological Protection guidance^[17], American Association of Physicists in Medicine dose-reporting recommendations, and the European Commission’s diagnostic reference level framework^[19].

Structuring the report for clinical clarity

Because lower extremity runoff studies are reviewed by a wide range of referring specialties — vascular surgery, interventional radiology, cardiology, podiatry, endocrinology, and primary care — the structure of the written report carries real clinical weight beyond its technical findings. A report organized consistently by named vessel segment, proceeding from the aorta to the pedal arch on each limb, is substantially easier for a non-radiologist to act on than a narrative organized by incidental finding order.

Explicitly stating the degree of confidence in distal vessel patency assessment, particularly when calcification or suboptimal opacification limits that confidence, gives the referring team the information they need to decide whether additional imaging or direct clinical correlation is warranted before committing to a treatment pathway.

Top 10 pathologies on CTA runoff

Lower extremity runoff studies are requested for a relatively narrow band of clinical indications, but the differential diagnosis encountered within that band is broader than many referring clinicians expect. The ten conditions below span the full spectrum from the overwhelmingly common — atherosclerotic PAD accounts for the substantial majority of positive findings — to genuinely rare developmental anomalies such as popliteal artery entrapment syndrome, which nonetheless carry outsized clinical importance because they typically affect younger patients in whom a missed diagnosis has decades of consequence. Reading these studies well requires holding both ends of that spectrum in mind simultaneously: pattern-matching efficiently to common PAD while remaining alert to the much rarer findings that change management entirely.

Several of these entities interact in ways that complicate a purely checklist-driven read. A patient with longstanding diabetic microangiopathy and heavy tibial calcification, for example, is simultaneously at higher risk of harbouring an acute embolic occlusion superimposed on chronic disease, of having that occlusion obscured by calcium blooming, and of presenting with an atherosclerotic ulcer whose arterial inflow status will determine whether revascularization is even feasible before a wound-care or amputation decision is made. Recognizing these overlapping pathologies — rather than anchoring on the first abnormality identified — is part of what distinguishes a genuinely useful runoff report from a technically accurate but clinically incomplete one.

Pitfalls for radiographers

The primary scanning pitfall for this protocol is outrunning the contrast bolus: in patients with severe PAD or reduced cardiac output, contrast travels down the leg more slowly than expected, and an ultra-fast acquisition can reach the feet before contrast has arrived there, producing a falsely non-opacified distal vasculature that mimics complete occlusion. This pitfall is worth dwelling on because, unlike many scanning errors, it does not produce an obviously degraded image — the resulting study can look technically clean, well-positioned, and free of motion artifact, while still being non-diagnostic in exactly the vessels the referring clinician most needs assessed.

A radiographer who has not been specifically trained to recognize the clinical risk factors for delayed bolus transit has no visual cue, at the console, that anything has gone wrong.

None of these pitfalls require expensive new equipment to solve; they require a consistent pre-scan habit of checking the referral and clinical history for markers of severe or advanced disease, and a willingness to deviate from the scanner’s default timing calculation when those markers are present. The single highest-value intervention available to a radiographer on this protocol is simply pausing, before the injection starts, to ask whether this particular patient’s vascular physiology matches the assumptions baked into the default acquisition.

Pitfalls for radiologists

The primary interpretation pitfall for this protocol is calcium blooming: dense mural calcification creates a blooming artifact that obscures the true vessel lumen, making partial stenosis appear as complete occlusion on standard reconstructions.

The physical basis of this artifact lies in a combination of beam-hardening — the preferential absorption of lower-energy photons as the X-ray beam passes through dense calcium, which shifts the effective beam energy and distorts the measured attenuation at the plaque margin — and the finite spatial resolution of the CT detector system itself, which causes the apparent edge of a small, very dense object to spread beyond its true physical boundary. Neither effect is unique to the lower extremity; the same physics underlies calcium blooming in coronary CTA.

What makes it especially consequential here is the combination of small vessel caliber and a patient population — diabetic, elderly, often dialysis-dependent — in whom dense, circumferential calcification is the rule rather than the exception.

A practical heuristic many experienced readers use is to treat the phrase “complete occlusion” in their own draft report as a prompt for a second look rather than a final conclusion, specifically asking whether the segment in question is densely calcified and whether the acquisition’s timing was appropriate for this patient’s likely transit speed. Where genuine diagnostic uncertainty remains after this second look, qualifying the report — for example, noting that severe calcification limits confident exclusion of a high-grade stenosis versus occlusion — gives the referring team more actionable information than a falsely confident binary statement.

Pitfalls for non-radiology physicians

Vascular surgeons, interventional cardiologists, endocrinologists managing diabetic patients, and primary care physicians are all regular consumers of CTA runoff reports, frequently under time pressure and without the opportunity to review the underlying images themselves. The pitfalls below reflect the gap that can open between precise radiological language and the clinical decisions that language is used to support. None of these pitfalls reflect a failure of the referring physician’s knowledge or judgment; they reflect the structural reality that a written report is a lossy compression of a much richer image dataset, and that compression occasionally discards exactly the nuance a treatment decision depends on.

The most reliable safeguard against all four of these pitfalls is the same one that appears throughout this article: direct communication between the ordering clinician and the reporting radiologist whenever a finding seems inconsistent with the clinical picture, or whenever a treatment decision of real consequence — amputation, a major bypass, withholding intervention — rests on a single imaging descriptor. A brief phone call or secure message that clarifies whether “occlusion” reflects definite pathology or a technically limited assessment costs little and can materially change the course of patient care.

Pitfall comparison summary

All three pitfalls share a common thread: each can independently cause a viable arterial segment to be misclassified as occluded. Closing the loop between the radiographer’s acquisition technique, the radiologist’s awareness of artifact, and the clinician’s willingness to question ambiguous “occlusion” language is the single most effective safeguard against an avoidable amputation decision. In practice, the departments that perform best on this metric are not necessarily those with the newest scanner hardware, but those that have built a habit of multidisciplinary discussion around ambiguous runoff cases — a five-minute conversation between the reporting radiologist and the referring vascular surgeon, before a treatment plan is finalized, often resolves exactly the kind of artifact-versus-pathology uncertainty this section describes.

Periodic departmental audit of runoff cases — comparing CTA-reported findings against subsequent catheter angiography, surgical findings, or duplex follow-up where available — is one of the most effective ways to detect a systemic pattern in any of these three pitfall categories before it accumulates into a meaningful clinical impact. A department that discovers, for example, that a disproportionate share of its “complete occlusion” calls in heavily calcified tibial vessels are later found to represent high-grade stenosis at intervention has identified a specific, correctable training or protocol gap rather than a series of unrelated isolated errors.

AI and automation in lower extremity CTA

Artificial intelligence tools for lower extremity CTA are maturing rapidly, with several recent peer-reviewed validations specifically targeting the femoropopliteal segment most prone to both disease and interpretive difficulty. A deep learning model trained on maximum intensity projection images from lower extremity CTA demonstrated the ability to screen for significant femoropopliteal steno-occlusion using a sequential single-image and four-segment rotational analysis approach, validated on a temporally distinct dataset^[7]. A separate evaluation of an AI algorithm applied to MR angiography for femoropopliteal steno-occlusion detection reported promising initial performance, underscoring that cross-modality AI vascular detection is an active area of development^[8].

Beyond stenosis detection, dual-energy calcium subtraction itself functions as a form of algorithmic post-processing that directly targets the calcium blooming interpretation pitfall, improving sensitivity and specificity for significant stenosis compared with standard reconstructions in head-to-head comparison against digital subtraction angiography^[4]. As these tools move from validation studies toward regulatory clearance and clinical deployment, radiology departments should evaluate AI-assisted runoff analysis as a complement to — not a replacement for — careful source-image review by a trained radiologist, particularly in heavily calcified or technically challenging studies.

From a workflow perspective, the most immediately practical role for automation in this protocol may not be diagnostic classification at all, but rather quality assurance at the point of acquisition. Automated tools that flag a study for technologist or radiologist review when distal vessel attenuation falls below a diagnostic threshold could, in principle, catch an outrun bolus before the patient leaves the department, converting what is currently a pitfall discovered only at the reporting stage — often hours later — into one identified and corrected in real time. Several vendors are actively developing acquisition-time quality metrics along these lines, though peer-reviewed validation specific to lower extremity runoff bolus adequacy remains an emerging rather than established area.

Departments piloting any AI tool in this space should track its performance against locally adjudicated ground truth before relying on it for clinical decision support, and should treat vendor marketing claims with the same scrutiny applied to any other diagnostic device.

A pre-finalization quality checklist for runoff studies

Before any lower extremity CTA runoff report is finalized, a brief structured check against the following items can catch the majority of avoidable errors discussed throughout this article.

• Confirm the bolus-tracking trigger location and threshold were appropriate, and check whether the patient’s clinical history flagged a risk of delayed distal transit.
• Visually confirm adequate luminal attenuation (generally above 150 HU) in the most distal opacified vessel before characterizing it, or any segment beyond it, as occluded.
• For any segment described as “complete occlusion,” specifically check for dense circumferential calcification that could be producing a blooming artifact rather than true occlusion.
• Trace each of the three tibial vessels individually to its terminal branches, rather than summarizing tibial runoff as a single collective assessment.
• Assess for and explicitly comment on collateral circulation when characterizing the chronicity of any occlusion.
• Cross-reference the angiosome of any active wound against the patency of its named source artery when the clinical indication involves non-healing ulceration.
• Review the contralateral limb with the same rigor as the symptomatic limb, particularly for aneurysmal disease, which is frequently bilateral.

Further reading

The following related articles from the 30-Day CT Protocol Mastery Series and SATMED Health’s broader education library expand on adjacent vascular CTA techniques, contrast safety, and injector practice referenced throughout this protocol.

1. 5 Master Mesenteric CTA Protocol Tactics
2. 7 Critical CTA Brain & Carotids Protocol Steps Every Radiographer Must Master
3. 7 Essential High-Pressure Injector Training Skills for Radiographers
4. 2026 Worldwide Guidelines for Safe Contrast Media Administration
5. CT Renal Mass Protocol: 7 Steps to Nail the Triple-Phase Scan

Conclusion

The CTA lower extremity runoff protocol demands a level of bolus-timing precision and interpretive caution that distinguishes it from almost every other CTA study in routine practice. Success depends on three coordinated safeguards: a radiographer who recognizes when a slow, diseased vascular bed requires an extended delay rather than the default scanner calculation; a radiologist who treats heavily calcified vessels with appropriate suspicion for blooming artifact rather than reflexively reporting complete occlusion; and a referring physician who understands that imaging language describing “occlusion” may reflect a technical limitation rather than definitive pathology.

None of these three safeguards is difficult or expensive to implement in isolation, yet together they require sustained, deliberate departmental culture rather than a single training session or protocol update. Embedding them into routine practice — through structured handover communication, periodic case review, and a shared vocabulary for describing diagnostic uncertainty — is what ultimately separates a department that occasionally gets this study right from one that reliably does so.

Across the ten pathologies most frequently encountered on this study — from common atherosclerotic PAD and acute embolic occlusion to the less frequent but clinically important popliteal aneurysm, dissection, pseudoaneurysm, arteriovenous fistula, popliteal entrapment, Buerger’s disease, diabetic microangiopathy, and atherosclerotic ulceration — the same underlying principle applies: a confidently correct CTA runoff report depends on a properly executed bolus, a calcium-aware read, and a clinical team willing to ask questions when the two do not align with the patient in front of them.

As scanner hardware, dual-energy and photon-counting acquisition, deep learning reconstruction, and early AI-assisted quality and detection tools continue to mature, the technical floor beneath this protocol will keep rising. None of that technology, however, removes the underlying physiologic reality that a contrast bolus takes time to travel the length of a diseased limb, or the underlying physical reality that dense calcium scatters and blooms beyond its true boundary on a CT image. Departments that build their training, their default delay settings, and their reporting habits around those two unavoidable facts will continue to produce reliable, clinically trusted runoff studies regardless of which scanner generation happens to be installed down the hall.

For radiographers, radiologists, and the surgical and interventional colleagues who depend on this study, that combination of disciplined technique and appropriate interpretive humility — rather than any single piece of hardware — remains the real foundation of a trustworthy lower extremity CTA runoff service.

References

1. Gornik, H. L., Aronow, H. D., Goodney, P. P., et al. (2024). 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 149(24). https://doi.org/10.1161/CIR.0000000000001251
2. Azene, E. M., Steigner, M. L., Aghayev, A., Ahmad, S., Clough, R. E., et al. (2022). ACR Appropriateness Criteria® lower extremity arterial claudication—imaging assessment for revascularization: 2022 update. Journal of the American College of Radiology, 19(11), S364–S373. https://doi.org/10.1016/j.jacr.2022.09.002
3. Horehledova, B., Mihl, C., Milanese, G., Brans, R., Eijsvoogel, N. G., Hendriks, B. M. F., Wildberger, J. E., & Das, M. (2018). CT angiography in the lower extremity peripheral artery disease: feasibility of an ultra-low volume contrast media protocol. CardioVascular and Interventional Radiology, 41(11), 1751–1764. https://doi.org/10.1007/s00270-018-1979-z
4. De Santis, D., De Cecco, C. N., Schoepf, U. J., Nance, J. W., Yamada, R. T., Thomas, B. A., Otani, K., Jacobs, B. E., Turner, D. A., Wichmann, J. L., Eid, M., Varga-Szemes, A., Caruso, D., Grant, K. L., Schmidt, B., Vogl, T. J., Laghi, A., & Albrecht, M. H. (2019). Modified calcium subtraction in dual-energy CT angiography of the lower extremity runoff: impact on diagnostic accuracy for stenosis detection. European Radiology, 29(9), 4783–4793. https://doi.org/10.1007/s00330-019-06032-y
5. Bucolo, G. M., D’Angelo, T., Yel, I., Koch, V., Gruenewald, L. D., Othman, A. E., Alizadeh, L. S., Overhoff, D. P., Waldeck, S., Martin, S. S., Mazziotti, S., Ascenti, G., Blandino, A., Vogl, T. J., & Booz, C. (2023). Virtual monoenergetic imaging of lower extremities using dual-energy CT angiography in patients with diabetes mellitus. Diagnostics, 13(10), 1790. https://doi.org/10.3390/diagnostics13101790
6. Stacy, M. R. (2022). Molecular imaging of lower extremity peripheral arterial disease: an emerging field in nuclear medicine. Frontiers in Medicine, 8, 793975. https://doi.org/10.3389/fmed.2021.793975
7. Hong, W., Kang, J., Kim, S. E., Jeong, T., Yoon, C. J., Lee, I. J., Kwon, L. M., & Cho, B.-J. (2025). Deep learning-based diagnosis of femoropopliteal artery steno-occlusion using maximum intensity projection images of CT angiography. Tomography, 11(9), 104. https://doi.org/10.3390/tomography11090104
8. Nguyen, T.-T., Folle, L., & Bayer, T. (2024). Detection of femoropopliteal arterial steno-occlusion at MR angiography: initial experience with artificial intelligence. European Radiology Experimental, 8, 33. https://doi.org/10.1186/s41747-024-00433-5
9. Improving lower-extremity artery depiction and diagnostic confidence using dual-energy technique and popliteal artery monitoring in dual-low dose CT angiography. (2025). Scientific Reports. https://doi.org/10.1038/s41598-025-97868-6
10. Torella, F., Lam, K., Neequaye, S., & McWilliams, R. G. (2021). Cross-sectional imaging of popliteal artery entrapment syndrome. Journal of Vascular Surgery Cases, Innovations and Techniques, 7(4), 716–718. https://doi.org/10.1016/j.jvscit.2021.09.012
11. Mustapha, J. A., Sarkar, R., & Rastogi, U. (2022). Awareness and early diagnosis of popliteal artery entrapment syndrome is needed. JACC: Case Reports, 4(8), 451–454. https://doi.org/10.1016/j.jaccas.2022.02.002
12. American Heart Association/American College of Cardiology Task Force on Clinical Practice Guidelines. (2017). 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary. Journal of the American College of Cardiology, 69(11), e71–e126. https://doi.org/10.1016/j.jacc.2016.11.007
13. Conte, M. S., Pomposelli, F. B., Clair, D. G., Geraghty, P. J., McKinsey, J. F., et al. (2015). Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. Journal of Vascular Surgery, 61(3 Suppl), 2S–41S. https://doi.org/10.1016/j.jvs.2014.12.009
14. Cooper, K., Majdalany, B. S., Kalva, S. P., et al. (2018). ACR Appropriateness Criteria® lower extremity arterial revascularization—post-therapy imaging. Journal of the American College of Radiology, 15(11S), S104–S115. https://acsearch.acr.org/list/TopicNarrativePdf?topicId=192
15. American College of Radiology, Society of Interventional Radiology, Society for Pediatric Radiology, & Society of NeuroInterventional Surgery. (2023). ACR–NASCI–SIR–SPR practice parameter for the performance and interpretation of body computed tomography angiography (CTA). American College of Radiology.
16. American College of Radiology Committee on Drugs and Contrast Media. (2023). ACR manual on contrast media. American College of Radiology.
17. International Commission on Radiological Protection. (2017). Diagnostic reference levels in medical imaging. ICRP Publication 135. Annals of the ICRP, 46(1).
18. International Commission on Radiological Protection. (2007). The 2007 recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Annals of the ICRP, 37(2–4).
19. European Commission. (2018). European guidelines on diagnostic reference levels for paediatric imaging (Radiation Protection No. 185). Publications Office of the European Union.
20. Damilakis, J., Frija, G., Brkljacic, B., et al. (2023). How to establish and use local diagnostic reference levels: an ESR EuroSafe Imaging expert statement. Insights into Imaging, 14, 27. https://doi.org/10.1186/s13244-023-01369-x
21. American Association of Physicists in Medicine. (2014). Size-specific dose estimates (SSDE) in pediatric and adult body CT examinations. AAPM Report No. 204.
22. Hong, W., et al. (2025). See reference 7 above for full deep learning steno-occlusion methodology applicable to AI-assisted runoff triage.
23. Khanna, A. K., & Hakim, M. Z. (2021). The management of ischemic limb in thromboangiitis obliterans (Buerger’s disease). Indian Journal of Surgery, 83, 836–844. https://pubmed.ncbi.nlm.nih.gov/?term=Khanna+Hakim+thromboangiitis
24. Arkkila, P. E. T. (2006). Thromboangiitis obliterans (Buerger’s disease). Orphanet Journal of Rare Diseases, 1, 14. https://doi.org/10.1186/1750-1172-1-14
25. Bo, Y., Xie, J., Xu, F., Yang, G., Li, D. L., & Yan, X. H. (2025). Comparison of three diagnostic imaging modalities for use in diabetic inferior arterial lesions. World Journal of Diabetes, 16(7), 107187. https://doi.org/10.4239/wjd.v16.i7.107187
26. Takahara, M. (2021). Diabetes mellitus and lower extremity peripheral artery disease. JMA Journal, 4(3), 225–231. https://doi.org/10.31662/jmaj.2021-0042